Sarepta Therapeutics, Inc. Share Price Today: Live Updates & Key Insights
Sarepta Therapeutics, Inc. share price today is $16.6, up 0.24%. The stock opened at $16.85 against the previous close of $16.65, with an intraday high of $17.29 and low of $16.54.
Sarepta Therapeutics, Inc. Share Price Chart
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Share Price Performance
Sarepta Therapeutics, Inc. Institutional Holdings
Sarepta Therapeutics, Inc. Market Status
Sarepta Therapeutics, Inc. Fundamentals
Market Cap 1752.28 M
PB Ratio 1.5372
PE Ratio 0.0
Enterprise Value 1853.42 M
Total Assets 3349.70 M
Volume 2864089
Sarepta Therapeutics, Inc. Company Financials
About Sarepta Therapeutics, Inc. & investment objective
Company Information Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Organisation Biotechnology
Employees 835
Industry Biotechnology
CEO Mr. Douglas S. Ingram Esq., J.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Sarepta Therapeutics, Inc. FAQs
What is the share price of Sarepta Therapeutics, Inc. today?
The current share price of Sarepta Therapeutics, Inc. is $16.6.
Can I buy Sarepta Therapeutics, Inc. shares in India?
Yes, Indian investors can buy Sarepta Therapeutics, Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Sarepta Therapeutics, Inc. shares in India?
You can easily invest in Sarepta Therapeutics, Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Sarepta Therapeutics, Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Sarepta Therapeutics, Inc..
Can I buy fractional shares of Sarepta Therapeutics, Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. has a market cap of $1752.28 M.
In which sector does Sarepta Therapeutics, Inc. belong?
Sarepta Therapeutics, Inc. operates in the Biotechnology sector.
What documents are required to invest in Sarepta Therapeutics, Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Sarepta Therapeutics, Inc.?
The PE ratio of Sarepta Therapeutics, Inc. is N/A and the PB ratio is 1.54.